Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference

Investor Relations Contact:

[email protected]

Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that its President and Chief Executive Officer, Dr. Chris Anzalone, will present a company overview at the 2012 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 14 at 4:15 pm Eastern time at Le Parker Meridien Hotel in New York City.

A live webcast of the presentation can be accessed by visiting the News & Events section of the company’s website, . A replay will also be archived on the website and available for 60 days.

Arrowhead Research Corporation is a clinical stage targeted therapeutics company with development programs in oncology, obesity, and infectious disease. The company is leveraging its platform technologies to design and develop peptide-drug conjugates (PDCs) that specifically home to cell types of interest while sparing off-target tissues, create targeted drugs based on the gene silencing RNA interference (RNAi) mechanism, and work with partners to create improved versions of traditional small molecule drugs.

For more information please visit , or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to .

Suggested Articles

NeoTX Therapeutics has nabbed a healthy $45 million third funding round as it looks to continue work on its early-stage cancer combo test.

Wedding Five Prime Therapeutics’ cabiralizumab to Bristol-Myers Squibb’s checkpoint inhibitor Opdivo has proved to be a bust in pancreatic cancer.

Sean Harper and Beth Seidenberg tell FierceBiotech how and why they set up their own VC firm, Westlake Village BioPartners.